The visit showcased some of the area’s most advanced innovation assets, including Thales Alenia Space’s Space Smart Factory, a cutting-edge satellite manufacturing facility, and Aruba’s Hyper Cloud Data Center, a key infrastructure supporting digital transformation, cloud computing, and data management.

Beyond celebrating the achievements already present within the Tecnopolo, the visit also brought significant announcements for the future of Rome’s innovation ecosystem.

Among the most notable developments is the planned creation of a dedicated Metro B station serving the Tecnopolo Tiburtino. The new transport infrastructure is expected to improve accessibility for researchers, entrepreneurs, students, and companies operating within the district, further strengthening its attractiveness as a hub for innovation and investment.

Equally important was the positive reception of the Italian Government’s proposed €1 billion investment in artificial intelligence and quantum technologies. The initiative represents a major opportunity to reinforce Italy’s competitiveness in strategic deep-tech sectors and could generate new opportunities for research institutions, startups, technology transfer organizations, and innovative enterprises across the country.

Today, the Tecnopolo Tiburtino hosts more than 150 companies active in sectors such as aerospace, ICT, life sciences, green technologies, and advanced manufacturing. The combination of world-class industrial facilities, growing digital infrastructure, and strong public investment confirms the district’s role as a cornerstone of Rome’s innovation ecosystem.

As Italy continues to invest in emerging technologies and advanced research, the Tecnopolo Tiburtino stands as a powerful example of how collaboration between industry, academia, and public institutions can drive sustainable economic growth and technological leadership.

Source: La Capitale, June 2026. Article: “Tecnopolo Tiburtino, Gualtieri in visita tra spazio, dati e innovazione: Roma punta sempre di più sulla tecnologia.“

The post Tecnopolo Tiburtino: Rome Strengthens Its Position as a Leading Innovation Hub appeared first on INNOVA.

• Research & discovery: 7.3 for academic reputation
• Learning experience: The teacher-student ratio of 6.1 highlights an educational approach that encourages direct contact between students and teachers.
• Global Engagement: The data on internationalization are particularly relevant, confirming the strengthening of the university’s international profile. 
• Outgoing student mobility scores 56.5, and incoming student mobility stands at 9.8.
• The international research network scores 22.8, reflecting active scientific collaborations at European and international level. 
• The picture is completed by the international ratio of teachers, with a score of 2.3, and the high diversity of nationalities present, scoring 61.8.
• Sustainability: On the issue of sustainability, which is increasingly central to the evaluation of universities, Unicas achieved a score of 44.8, confirming its strong focus on environmental and social policies. 
• Employability: In terms of employability, the ranking assigns a score of 4.8 to corporate reputation and 9.8 to employment outcomes. 
• These two indicators reflect the relationship between university education and the world of work. 
• The presence of Unicas in the ranking has a value that goes beyond numerical data: it is a sign of constant engagement, a clear vision, and a strong connection with the local area. 

This result strengthens the University’s role in the European academic landscape and allows it to look forward to future challenges with confidence.

European University of Technology 

#Europe #UnicasSostenibile #InternationalUnicas #EuropeUnicas #TerritorioUnicas #QSRankings2026

Source: Link 

The post UNICAS is among the top 500 universities in the QS World University Rankings: Europe 2026 appeared first on INNOVA.

About the Initiative

The Faber School-Urban Living Lab SMILE City is a dynamic co-design and prototyping programme that invites multidisciplinary talents to respond to one of SMILE CITY’s core innovation challenges: the design of an off-grid e-bike charging station powered by renewable energy and built with circular economy principles. This station will serve as a scalable infrastructure prototype for sustainable urban mobility across European cities. 

By joining this initiative, participants will collaborate within an international ecosystem of partners drawn from research institutions, industry, local authorities, universities and civil society, contributing to a real-world solution that embodies sustainability, functional design, and technical feasibility.

Who Can Participate

The call welcomes applications from a broad spectrum of profiles, including:

• University and ITS students
• Recent graduates, researchers and scientists
• Designers, architects and makers
• Digital artisans, technicians and local innovators
• Professionals and companies interested in sustainable design, renewable energy and circular economy solutions

This multidisciplinary cohort ensures a rich blend of perspectives and competences throughout the ideation and prototyping phases.

Challenge Focus and Expected Outcomes

Participants are invited to develop a functional architectural concept that integrates:

• A robust support structure for roof-mounted photovoltaic panels
• A secure and accessible housing for second-life batteries for energy storage
• Optional elements enhancing urban experience, including seating, lighting, and information interfaces

Design proposals should balance aesthetics, functionality, durability, safety, and replicability, while reflecting the principles of circular economy and urban sustainability championed by the SMILE CITY project. 

Programme Structure

The initiative is structured in four key phases:

1. Introductory Workshops: A series of preparatory sessions to:
   • Present the SMILE CITY partnership and its expertise network
   • Deep-dive into the call objectives and technical materials
   • Facilitate networking and exchange among participants and project partners
2. The first workshop took place on 3 December 2025 at CNR – Rome, with follow-ups in early 2026 at Sapienza University, Politecnico di Torino and ISIA Faenza.
3. Call for Applications: Submissions are open until 10 January 2026 (18:00 CET). Applications are evaluated by a panel including representatives from Lazio Innova, ETRA and sector experts.
4. Co-Design and Prototyping Phase: A blended programme of in-person and digital sessions hosted through the FabLab network and across partner locations, fostering cross-fertilisation among international teams.
5. Demo Day & Final Presentation: Each working group will present a suite of outputs from CAD drawings and scale models to presentations and illustrative media  before an international expert jury.

Selected teams will gain:

• Involvement in SMILE CITY project activities,
• Recognition and visibility across project communications,
• Rights to reference their concept and prototype in professional portfolios,
• Travel cost reimbursement for project-related meetings.

Why It Matters

Urban Living Labs like this embody Europe’s push for participatory innovation, linking design, technology, sustainability and community needs within real urban contexts. The SMILE CITY project aims to pioneer circular, low-emission urban environments, with infrastructure solutions that are adaptable, scalable and citizen-centric.

This open call not only creates tangible outcomes in sustainable mobility infrastructure but also fosters international collaboration, knowledge exchange, and real-world impact for participants poised to become leaders in innovation, design and sustainability.

Apply and Engage

Interested innovators and teams are encouraged to apply by 10 January 2026. For full details and application procedures, Click Here 

The post Faber School: Urban Living Lab “SMILE City”: Call for Co-Creation and Prototyping of Sustainable Urban E-Mobility Solutions appeared first on INNOVA.

The article highlights the launch of Scuter’s new sharing service in Milan, introducing 200 electric three-wheel vehicles designed and developed in Italy.

Scuter combines comfort, safety, and sustainability in a unique way, offering the convenience of a scooter with the protection and stability of a car, all without the need for a helmet. With its lightweight design, electric propulsion, and user-friendly digital platform, Scuter aims to revolutionize urban micro-mobility and reduce emissions in city centers.

This recognition reaffirms Scuter’s commitment to innovation, safety, and sustainability, setting a new standard for the future of clean transportation in Europe.

Source: Corriere della Sera

#Scuter #INNOVA #MobilityInnovation #MadeInItaly #SustainableTransport #UrbanMobility #Innovation #Cleantech

The post Scuter: Made in Italy Innovation Driving the Future of Urban Mobility appeared first on INNOVA.

The post EIC ACCESS+ initiative Open Call appeared first on INNOVA.

Inavya Ventures created AVATR, a regulated medical-grade device.

This device is compatible with other medical devices and aids in the collection of accurate environmental, social, and behavioral data from patients.

The ultimate goal of this device is to ensure the well-being of patients outside the hospital. The goal of this novel augmented intelligence system is to provide personalized medicine on a large scale and across borders.

AVATR: An Al-Powered Revolutionary Advancement

AVATR technology, created by Inavya Ventures, enables people to create, manage, and share their quantified selves using a smartphone in order to get individualized medical care whenever and wherever they need it.

Drawing on Sanskrit philosophical concepts of self and blending medical, scientific, and technological advancements, AVATR empowers individuals to live well autonomously.

AVATR leverages AI to deliver personalized medical care at a large scale. By continuously analyzing multifactorial data, it helps medical professionals to customize care to each patient’s unique needs, circumstances, and preferences. Its user-friendly interface and compatibility across devices make advanced healthcare universally accessible.

Inavya collaborates with top global healthcare institutions to transform healthcare delivery, optimizing resources and enhancing system efficiency. AVATR is positioned as an invaluable resource for reducing costs and improving outcomes, establishing a new benchmark in AI-driven healthcare.

The Unwavering Path Of Advancement

Since its inception in 2015, AVATR has been at the forefront of healthcare technology innovation.

From its early development to global recognition, AVATR has consistently pushed the boundaries of personalized medicine. Its collaborations with leading NHS hospitals have honed and validated its capabilities, while expansions into markets such as Peru, Brazil and Singapore demonstrate its adaptability across diverse healthcare environments. AVATR’s milestones reflect its commitment to enhancing healthcare outcomes worldwide.

In recognition of its innovation, the UK government has distinguished Inavya as a One World Company and a First

100 Playbook Company. Inavya has also earned accolades such as ‘Best Startup London – 2023, ‘Precision Medicine Startup of the Year – 2023, and was listed among the ‘Top-10 Innovators – 2024’. These honors underscore Inavya’s leadership in advancing medical technology and its global impact. .

Further enhancing its efforts, Inavya has partnered with HealthSum AS, a Norwegian-Swiss company pioneering a novel Electronic Health Record (EHR) platform built on Distributed Ledger Technology (DLT) to transform healthcare globally. The partnership ensures unmatched data security, cost efficiency, and environmental protection.

As noted by Nigel J. Green, HealthSum’s COO –

“HealthSum AS and Inavya, with their innovative AVATR platform, are combining strengths to bridge the gap between Real World Evidence (RWE) and Real World Data (RWD). We reconstitute fragmented health data streams into a cohesive, patient-centric digital ecosystem by integrating our advanced AI and machine learning capabilities.

This allows physicians to make better and faster decisions while patients regain ownership of their digital selves for better health outcomes. Together, we are making personalized, precision medicine accessible to everyone, empowering individuals to take charge of their health and transforming the healthcare landscape.”

The AVATR’s user-friendly interface

AVATR’s user-friendly interface, crafted by designers John Walters and Chris da Costa, sets a new standard for accessibility in healthcare technology. It empowers patients to interact effortlessly by integrating robust functionality with intuitive design principles, providing a clean and easy experience.

A standout feature is its comprehensive multilingual support, reflecting AVATR’s commitment to serving diverse populations globally. This ensures language barriers don’t hinder access to essential services.

AVATR prioritizes simplicity without compromising functionality. Its design guides users through complex medical data and treatment options, making information easy to understand and act upon. Users confidently navigate the AVATR interface, whether they are accessing records, creating care plans, or receiving treatment

recommendations.

This interface represents a major paradigm shift in healthcare technology, bringing the potential of cutting-edge Al-driven solutions to a global audience.

The AVATR’s compatibility score

AVATR is engineered to operate across various devices, including mobile phones, laptops, and tablets. This compatibility is crucial for ensuring patients can access personalized medical care regardless of their technological resources or location.

The Role of AVATR in Global Healthcare

By partnering with institutions like the NHS and pioneering projects in Peru and Brazil, Inavya seeks to transform healthcare worldwide.

At its core, AVATR democratizes access to personalized healthcare, ensuring everyone benefits regardless of socioeconomic status or location. Focusing on care plan adherence, AVATR addresses diverse population needs, particularly in underserved regions. Ongoing projects in Peru and Brazil demonstrate AVATR’s commitment to tackling global health disparities. Leveraging its scalable platform, AVATR aims to bridge healthcare access gaps and improve outcomes for communities in need.

Planned expansion into Mexico and the USA signifies a bold step towards broader impact and growth.

Safety and Privacy: First and foremost

At Inavya, safeguarding patient data privacy and security is our highest priority. We employ cutting-edge encryption methods and adhere rigorously to data protection regulations to ensure the utmost protection of personal information.

Data collection undergoes stringent monitoring to prevent unauthorized access or breaches.

In a groundbreaking stride towards enhanced security, Inavya’s collaboration with HealthSum AS integrates decentralized storage, Al at the edge, and distributed ledger technology.

This amalgamation ensures unparalleled privacy and security and instills trust among patients, clinicians, and stakeholders.

HealthSums’ implementation of Kubernetes scaling orchestration optimizes energy consumption in line with industry sustainability standards, while bolstering our data security infrastructure.

AVATR: A Revolution in the Medical Domain

Equipped with advanced Al capabilities, AVATR employs predictive analytics to identify early health indicators, preventing adverse outcomes and reducing costs. Clinicians can proactively develop optimized treatment plans by analyzing patient data in real-time, enhancing efficacy and adherence.

The Rome-based team at Inavya, led by Aleardo Furlani, consists of highly skilled Al developers, including Dr.

Alessio Gugliotta, Dr. Marko Vujasinovic, Edoardo Gazzella, Dr. Remo Pomposini, and Dr. Damiano D’Amici. This team is pivotal in developing the core technical build and providing operational support, which is essential for driving Inavya’s cutting-edge healthcare innovations forward.

With sponsorship from Microsoft, Dr. Peter Sahota is spearheading the development of novel GenAl agents for AVATR to revolutionize workflows and decision-making.

AVATR’s synthetic multidisciplinary teams enhance pharmaceutical research and personalized patient healthcare by analyzing extensive datasets and applying expert knowledge collaboratively. For scientists, these teams accelerate drug discovery and validate drug efficacy, and for clinicians, they enable the tailoring of patient care plans to support optimal clinical decision-making. Rival synthetic teams can be instructed to challenge and peer-review decisions of the assigned team, enabling continuous improvement and refinement of AVATR’s algorithms through machine learning.

Affordable Excellence, The Promise of Inavya

Inavya ensures the cost-effectiveness of its Al-backed services through strategic investments, including Deepbridge’s capital and expert guidance from Dr. Andrew Round and Ben Carter. These investments validate Inavya’s vision, attracting further support from the investor community.

Additionally, Inavya secures R&D grants and contracts to supplement its financial resources, accelerating innovation while accessing specialized expertise. Its lean operational model and effective governance minimizes overhead costs without compromising quality, further enhancing efficiency.

Strategic commercial partnerships provide access to additional resources and market opportunities, bolstering the cost-effectiveness of its services. Overall, Inavya’s financial strategy – combining investments, grants, and contracts with lean operations, technology deployments and strategic partnerships – drives innovation and delivers significant value to clients and stakeholders.

Insightful Leadership Of Michael Wilkinson, the CEO & Founder Of Inavya Ventures

At the helm of Inavya stands Dr Michael Wilkinson, a visionary leader with a passion for driving healthcare innovation.

With a background that spans the UK and the USA, Michael brings a wealth of experience to deliver the Inavya vision. Holding a PhD from Warwick University Medical School and boasting previous appointments at prestigious institutions such as the NHS, LSHTM, Cabinet Office, and Rush Hospital in Chicago, Michael’s leadership is underpinned by a deep understanding of the healthcare landscape and an unwavering commitment to improving health outcomes.

As the CEO and Co-Founder, Michael is not only a visionary, he is a team player who fosters collaboration. He understands the value of assembling a diverse team of experts who bring different perspectives, networks, and skill sets, driving innovation and excellence in every aspect of Inavya’s operations. Key team members contribute to Michael’s vision of Al-enabled healthcare transformation, including non-executive board directors Aleardo Furlani and Jack Tsang, as well as investor relations manager Thomas Szczepaniak.

Co-founder Aleardo Furlani — who earned an MBA at IESE Business School and studied at the Harvard JFK School

of Government – founded Innova, a prominent science and technology accelerator in Rome, Italy. With a proven track record, Aleardo has successfully incubated numerous companies, facilitating their growth in international markets.

Leveraging his robust credentials, Aleardo contributes exceptional business insight and board-level expertise to Inavya’s global operations and governance. With his expertise in technology transaction law spanning the UK and international markets, Jack Tsang provides invaluable strategic support for UK and international expansion, ensuring that Inavya optimally navigates complex investment and regulatory landscapes. With premium scientific, business and venture capital credentials, Thomas Szczepaniak is pivotal in strategically pacing and positioning

Inavya’s investment.

Together, Michael Wilkinson, Aleardo Furlani, Jack Tsang, and Thomas Szczepaniak form a formidable leadership team. They drive Inavya forward with a shared vision of leveraging AI technology to revolutionize healthcare delivery and improve patient outcomes globally. Their collaborative efforts and diverse expertise drives the company’s success, ensuring that Inavya remains at the forefront of global innovation in the healthcare industry.

Actual Testimonials From Happy Clients

“AVATR transcends current health approaches by leveraging the transformative potential of generative AI in patient follow-up. Its innovative approach is revolutionizing healthcare pathways, particularly for chronic patients who require continuous monitoring and personalized care. It’s improving the quality of life for patients, empowering them to lead healthier and more fulfilling lives, while bringing cost-effectiveness to the health ecosystem.” — Guilherme Robello, Head of Innovation, InCor Hospital, Sao Paulo, BRAZIL

“Avatr breaks down geographical, cultural, and economic barriers, harnessing the power of generative Al in patient follow-up, to improve outcomes, and elevate patient’s quality of life” – Dr Claudia A. Sedano Porras,

Head of R&D, Detecta Clinic, Lima, PERU.

Company Name: Inavya ventures Ltd

Website: www.avatr.ai

Co-founder: Aleardo Furlani

Founder & CEO: Michael Wilkinson

Source: The CEO Vision 
https://theceovision.com/revolution-through-evolution-the-innovative-journey-of-inavya-ventures-and-ai/

The post Revolution Through Evolution: The Innovative Journey Of Inavya Ventures And Al appeared first on INNOVA.

The study is available at the link below:

https://ec.europa.eu/digital-single-market/en/news/benchmarking-parental-control-tools-online-protection-children

The post Benchmarking of parental control tools for the online protection of children appeared first on INNOVA.

“L’Economia arancione: storie e politiche della creatività” (Rubbettino Editore, Economia e Finanza) è il titolo del libro pubblicato da Gian Paolo Manzella dedicato al tema dell’economia creativa. Il volume sarà al centro dell’incontro che si terrà il 12 settembre 2017 presso il MAXXI di Roma.

The post L’economia arancione: Storie e politiche della creatività appeared first on INNOVA.

The post The Newsletter from SmartLocalNet appeared first on INNOVA.

NAMDIATREAM has successfully developed innovative diagnostic devices for the early diagnosis of 3 common cancer types (lung, breast and prostate) representing more than 4,5 million worldwide cancer cases in the year 2012. NAMDIATREAM technology is based on cutting edge nanotechnology-based tools for multi-modal detection of biomarkers, permitting identification of cells indicative of early disease onset in a high-specificity and throughput format in clinical, laboratory and point-of-care devices. INNOVA has been in charge of project management, has coordinated the development of the strategic plan for the exploitation of project results and has delivered professional training workshops related to Technology Transfer and IPR management and valorisation.

The post The NAMDIATREAM project as the winner of the BEST EU-funded PROJECT competition! appeared first on INNOVA.

More information in Italian

The post Innova become a certified business incubator! appeared first on INNOVA.

The initiative aims to boost the participation of Italian SMEs and startups to the internationalization process, giving detailed information about the American startups scenario and creating links between Italian companies, operating in high technological fields, and US companies and subjects which are interested in taking advantage of the possibilities offered by the plurality of funds addressed to the field and considering the possibility of presenting joint projects to be proposed to the American venture capitalist. The conference represents an important bilateral moment for Italian companies on one side, who have the interest in starting a collaboration with the USA and are willing to test their products on the most challenging market, and for active Boston-based entrepreneurs, researchers, technology developers, investors and professionals interested in learning about Italian research & tech excellence and willing to establish an industrial/scientific collaboration with Italian partners on the other side.

After the conference, the participants are invited to a networking aperitivo, which will close the first day of work. On the 28th there will be the opportunity to hold bilateral meetings between the US participants and the Italian delegation (companies, INNOVA S.p.A., INNOVA Consulting Group and ICE).

The event is free but registration is required at the following link.

The post Save the date for the two-day conference in Boston on public funding and joint collaboration between Italy and USA appeared first on INNOVA.